Transkript

1

2

3

4

5

6 Nomeco A/S Årsrapport 2015/16 Annual report 2015/16 Ledelsesberetning Management's review Oplysninger om selskabet Company details Navn/Name Adresse, postnr., by/address, Postal code, City Nomeco A/S Borgmester Christiansens Gade 40, 2450 København SV CVR-nr./CVR No Regnskabsår/Financial year 1. februar januar/1 February - 31 January Telefon/Telephone Telefax/Telefax Bestyrelse/Board of Directors Direktion/Executive Board Revision/Auditors Øyvind Andreas Winther, formand/chairman Henrik Kaastrup Jan Bonde Sarah Weinreich Marsh Jan Augustinus Henrik Kaastrup Ken Rasmussen Per Hansen Ernst & Young Godkendt Revisionspartnerselskab Osvald Helmuths Vej 4, P O Box 250, 2000 Frederiksberg, Denmark 5

7

8

9

10

11

12

13

14

15

16

17 Nomeco A/S Årsrapport 2015/16 Annual report 2015/16 Årsregnskab 1. februar januar Financial statements for the period 1 February - 31 January Noter Notes to the financial statements 1 Anvendt regnskabspraksis Accounting policies Årsrapporten for Nomeco A/S for 2015/16 er aflagt i overensstemmelse med årsregnskabslovens bestemmelser for store klasse C- virksomheder. Årsregnskabet er aflagt efter samme regnskabspraksis som sidste år. Selskabet er den 1. februar 2015 fusioneret med det tidligere dattervirksomhed Forex A/S. Fusionen er foretaget efter sammenlægningsmetoden. Derfor er sammenligningstal tilpasset for regnskabsår, der ligger forud for den koncerninterne virksomhedssammenslutning, herunder også 5-års oversigten for hoved- og nøgletal. Undladelse af pengestrømsopgørelse Med henvisning til ÅRL 86, stk. 4, udarbejdes ikke pengestrømsopgørelse for modervirksomheden, da modervirksomhedens pengestrømme indgår i den samlede pengestrømsopgørelse for koncernen. Koncernregnskab Med henvisning til årsregnskabslovens 112, stk. 1 udarbejdes ikke koncernregnskab. Årsregnskabet for Nomeco A/S og dets tilknyttede virksomheder indgår i koncernregnskabet for Phoenix Pharmahandel Aktiengesellchaft & Co KG., Tyskland. Rapporteringsvaluta Årsregnskabet er aflagt i danske kroner. Valutaomregning Transaktioner i fremmed valuta omregnes ved første indregning til transaktionsdagens kurs. Valutakursdifferencer, der opstår mellem transaktionsdagens kurs og kursen på betalingsdagen, indregnes i resultatopgørelsen som en finansiel post. The annual report of Nomeco A/S for 2015/16 has been presented in accordance with the provisions of the Danish Financial Statements Act as regards large reporting class C enterprises. The accounting policies applied by the Company are consistent with those of last year. At 1 February 2015, the Company merged with the former subsidiary Forex A/S. The merger was implemented in accordance with the uniting-of-interests method. Therefore, the comparative figures were restated for financial years preceding the intra-group business combination, including the five-year survey of financial highlights. Omission to present a cash flow statement With reference to section 86(4) of the Danish Financial Statements Act, no cash flow statement for the parent company is prepared, as the parent company's cash flows are part of the consolidated cash flow statement. Consolidated financial statements Referring to section 112(1) of the Danish Financial Statements Act, no consolidated financial statements are prepared. The financial statements for Nomeco A/S and its group entities are part of the consolidated financial statements for Phoenix Pharmahandel Aktiengesellchaft & Co KG., Germany. Reporting currency The financial statements are presented in Danish kroner. Currency translation On initial recognition, transactions denominated in foreign currencies are translated at the exchange rates at the transaction date. Foreign exchange differences arising between the exchange rates at the transaction date and at the date of payment are recognised in the income statement as financial income or financial expenses. 16

18

19

20

21

22

23

24

25

26

27

28

29

30